Uptake by human glioma cell lines and biological effects of a peptide-nucleic acids targeting miR-221

Journal of Neuro-Oncology

Volumn 118, Issue 1, 2014, Pages 19-28

  Brognara, Eleonora ^a   Fabbri, Enrica ^a   Bazzoli, Elena ^b,e   Montagner, Giulia ^a   Ghimenton, Claudio ^c   Eccher, Albino ^c   Cantù, Cinzia ^c   Manicardi, Alex ^d   Bianchi, Nicoletta ^a   Finotti, Alessia ^a   Breveglieri, Giulia ^a   Borgatti, Monica ^a   Corradini, Roberto ^d   Bezzerri, Valentino ^c   Cabrini, Giulio ^c   Gambari, Roberto ^a  

^a UNIVERSITY OF FERRARA   (Italy)

^b IRCCS ISTITUTO CENTRO SAN GIOVANNI DI DIO FATEBENEFRATELLI   (Italy)

^c UNIVERSITY HOSPITAL OF VERONA   (Italy)

^d UNIVERSITY OF PARMA   (Italy)

^e UNIVERSITY OF VERONA   (Italy)

Author keywords

Delivery; Glioma; MicroRNAs; MiR 221; MiRNA targeting; Peptide nucleic acids

Indexed keywords

CYCLIN DEPENDENT KINASE INHIBITOR 1B; MICRORNA 221; OCTAARGININE NUCLEIC ACID PEPTIDE A221 CONJUGATE; POLYPEPTIDE; TISSUE INHIBITOR OF METALLOPROTEINASE 3; UNCLASSIFIED DRUG; LIPOCORTIN 5; MICRORNA; MIRN221 MICRORNA, HUMAN; PEPTIDE NUCLEIC ACID;

ANTINEOPLASTIC ACTIVITY; ARTICLE; CELL TRANSPORT; CLINICAL ARTICLE; CONCENTRATION RESPONSE; CONTROLLED STUDY; DRUG STRUCTURE; GENE EXPRESSION REGULATION; GLIOMA; GLIOMA CELL LINE; HUMAN; HUMAN CELL; PROTEIN EXPRESSION; PROTEIN RNA BINDING; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; TIMP3 GENE; UPREGULATION; WESTERN BLOTTING; ADULT; ANALYSIS OF VARIANCE; APOPTOSIS; BRAIN TUMOR; CELL PROLIFERATION; CHEMICAL STRUCTURE; DOSE RESPONSE; DRUG EFFECTS; FLOW CYTOMETRY; GENETICS; MALE; METABOLISM; TIME; TUMOR CELL LINE;

ADULT; ANALYSIS OF VARIANCE; ANNEXIN A5; APOPTOSIS; BRAIN NEOPLASMS; CELL LINE, TUMOR; CELL PROLIFERATION; CYCLIN-DEPENDENT KINASE INHIBITOR P27; DOSE-RESPONSE RELATIONSHIP, DRUG; FLOW CYTOMETRY; GENE EXPRESSION REGULATION, NEOPLASTIC; GLIOMA; HUMANS; MALE; MICRORNAS; MODELS, MOLECULAR; PEPTIDE NUCLEIC ACIDS; TIME FACTORS;

EID: 84901590950     PISSN: 0167594X     EISSN: 15737373     Source Type: Journal    
DOI: 10.1007/s11060-014-1405-6     Document Type: Article

References (50)

1. Nielsen PE, Egholm M, Berg RH, Buchardt O (1991) Sequence-selective recognition of DNA by strand displacement with a thymine-substituted polyamide. Science 254:1497-1500 (Pubitemid 21917487)
2. Nielsen PE (2001) Targeting double stranded DNA with peptide nucleic acid (PNA). Curr Med Chem 8:545-550
3. Borgatti M, Lampronti I, Romanelli A, Pedone C, Saviano M et al (2003) Transcription factor decoy molecules based on a peptide nucleic acid (PNA)-DNA chimera mimicking Sp1 binding sites. J Biol Chem 278:7500-7509 (Pubitemid 36800757)
4. Gambari R (2001) Peptide-nucleic acids (PNAs): a tool for the development of gene expression modifiers. Curr Pharm Des 7:1839-1862
5. Gambari R (2004) Biological activity and delivery of peptide nucleic acids (PNA)-DNA chimeras for transcription factor decoy (TFD) pharmacotherapy. Curr Med Chem 11:1253-1263
6. Nielsen PE (2010) Peptide nucleic acids (PNA) in chemical biology and drug discovery. Chem Biodivers 7:786-804
7. Hatamoto M, Ohashi A, Imachi H (2010) Peptide nucleic acids (PNAs) antisense effect to bacterial growth and their application potentiality in biotechnology. Appl Microbiol Biotechnol 86:397-402
8. Gambari R, Borgatti M, Bezzerri V, Nicolis E, Lampronti I et al (2010) Decoy oligodeoxyribonucleotides and peptide nucleic acids-DNA chimeras targeting nuclear factor kappa-B: inhibition of IL-8 gene expression in cystic fibrosis cells infected with Pseudomonas aeruginosa. Biochem Pharmacol 80:1887-1894
9. Pandey VN, Upadhyay A, Chaubey B (2009) Prospects for antisense peptide nucleic acid (PNA) therapies for HIV. Expert Opin Biol Ther 9:975-989
10. Nielsen PE (2010) Gene targeting and expression modulation by peptide nucleic acids (PNA). Curr Pharm Des 16:3118-3123
11. Manicardi A, Fabbri E, Tedeschi T, Sforza S, Bianchi N et al (2012) Cellular Uptakes, biostabilities and anti-miR-210 activities of chiral Arginine-PNAs in leukaemic K562 cells. Chembiochem 13:1327-1337
12. Fabbri E, Manicardi A, Tedeschi T, Sforza S, Bianchi N et al (2011) Modulation of the biological activity of microRNA-210 with peptide nucleic acids (PNAs). ChemMedChem 6:2192-2202
13. Gambari R, Fabbri E, Borgatti M, Lampronti I, Finotti A et al (2011) Targeting microRNAs involved in human diseases: a novel approach for modification of gene expression and drug development. Biochem Pharmacol 82:1416-1429
14. Fabani MM, Gait MJ (2008) MiR-122 targeting with LNA/2′-O-methyl oligonucleotide mixmers, peptide nucleic acids (PNA), and PNA-peptide conjugates. RNA 14:336-346 (Pubitemid 351171593)
15. Fabani MM, Abreu-Goodger C, Williams D, Lyons PA, Torres AG et al (2010) Efficient inhibition of miR-155 function in vivo by peptide nucleic acids. Nucleic Acids Res 38:4466-4475
16. Brown PN, Yin H (2013) PNA-based microRNA inhibitors elicit anti-inflammatory effects in microglia cells. Chem Commun (Camb) 49:4415-4417
17. Kip1 expression in breast cancer MDA-MB-231 cells. Int J Oncol 41:2119-2127
18. He L, Hannon GJ (2010) MicroRNAs: small RNAs with a big role in gene regulation. Nat Rev Genet 5:522-531
19. Piva R, Spandidos DA, Gambari R (2013) From microRNA functions to microRNA therapeutics: novel targets and novel drugs in breast cancer research and treatment. Int J Oncol 43:985-994
20. Shah MY, Calin GA (2011) MicroRNAs miR-221 and miR-222: a new level of regulation in aggressive breast cancer. Genome Med 3:56
21. Lambertini E, Lolli A, Vezzali F, Penolazzi L, Gambari R, Piva R (2012) Correlation between Slug transcription factor and miR-221 in MDA-MB-231 breast cancer cells. BMC Cancer 12:445
22. Galardi S, Mercatelli N, Giorda E, Massalini S, Frajese GV et al (2007) MiR-221 and miR-222 expression affects the proliferation potential of human prostate carcinoma cell lines by targeting p27Kip1. J Biol Chem 282:2316-2324
23. Zhang C, Zhang J, Hao J, Shi Z, Wang Y et al (2012) High level of miR-221/222 confers increased cell invasion and poor prognosis in glioma. J Transl Med 10:119
24. Zhang CZ, Zhang JX, Zhang AL, Shi ZD, Han L et al (2010) MiR-221 and miR-222 target PUMA to induce cell survival in glioblastoma. Mol Cancer 9:229
25. Lakomy R, Sana J, Hankeova S, Fadrus P, Kren L et al (2011) MiR-195, miR-196b, miR-181c, miR-21 expression levels and O-6-methylguanine-DNA methyltransferase methylation status are associated with clinical outcome in glioblastoma patients. Cancer Sci 102:2186-2190
26. Le Sage C, Nagel R, Egan DA, Schrier M, Mesman E (2007) Regulation of the p27(Kip1) tumor suppressor by miR-221 and miR-222 promotes cancer cell proliferation. EMBO J 26:3699-3708 (Pubitemid 47236875)
27. Lorimer IA (2009) Regulation of p27Kip1 by miRNA 221/222 in glioblastoma. Cell Cycle 8:2685
28. Bhatia B (2010) On the move: p27Kip1 drives cell motility in glioma cells. Cell Cycle 9:1231-1240
29. Lu X, Zhao P, Zhang C, Fu Z, Chen Y et al (2009) Analysis of miR-221 and p27 expression in human gliomas. Mol Med Rep 2:651-656
30. Gillies JK, Lorimer IA (2007) Regulation of p27Kip1 by miRNA 221/222 in glioblastoma. Cell Cycle 6:2005-2009 (Pubitemid 47327888)
31. Ueda R, Kohanbash G, Sasaki K, Fujita M, Zhu X et al (2009) Dicer-regulated microRNAs 222 and 339 promote resistance of cancer cells to cytotoxic T-lymphocytes by down-regulation of ICAM-1. Proc Natl Acad Sci USA 106:10746-10751
32. Zerrouqi A, Pyrzynska B, Febbraio M, Brat DJ, Van Meir EG (2012) P14ARF inhibits human glioblastoma-induced angiogenesis by upregulating the expression of TIMP3. J Clin Invest 122:1283-1295
33. Wang Y, Wang X, Zhang J, Sun G, Luo H et al (2012) MicroRNAs involved in the EGFR/PTEN/AKT pathway in gliomas. J Neurooncol 106:217-224
34. Zhang C, Kang C, You Y, Pu P, Yang W (2009) Co-suppression of miR-221/222 cluster suppresses human glioma cell growth by targeting p27Kip1 in vitro and in vivo. Int J Oncol 34:1653-1660
35. Schiappacassi M, Lovat F, Canzonieri V, Belletti B, Berton S et al (2008) p27Kip1 expression inhibits glioblastoma growth, invasion, and tumor-induced neoangiogenesis. Mol Cancer Ther 7:1164-1175
36. Tabu K, Ohnishi A, Sunden Y, Suzuki T, Tsuda M et al (2006) A novel function of OLIG2 to suppress human glial tumor cell growth via p27Kip1 transactivation. J Cell Sci 119:1433-1441
37. Cao X, Gu Y, Jiang L, Wang Y, Liu F et al (2013) A new approach to screening cancer stem cells from the U251 human glioma cell line based on cell growth state. Oncol Rep 29:1013-1018
38. Abdullah NA, Sallis B, Nuttall R, Schubert FR, Ahsan M et al (2012) Induction of apoptosis and reduction of MMP gene expression in the U373 cell line by polyphenolics in Aronia melanocarpa and by curcumin. Oncol Rep 28:1435-1442
39. Pen A, Durocher Y, Slinn J, Rukhlova M, Charlebois C et al (2011) Insulin-like growth factor binding protein 7 exhibits tumor suppressive and vessel stabilization properties in U87MG and T98G glioblastoma cell lines. Cancer Biol Ther 12:634-646
40. Abes R, Arzumanov A, Moulton H, Abes S, Ivanova G (2008) Arginine-rich cell penetrating peptides: design, structure-activity, and applications to alter pre-mRNA splicing by steric-block oligonucleotides. J Pept Sci 14:455-460 (Pubitemid 351540906)
41. Jensen KK, Orum H, Nielsen PE, Nordén B (1997) Kinetics for hybridization of peptide nucleic acids (PNA) with DNA and RNA studied with the BIAcore technique. Biochemistry 36:5072-5077 (Pubitemid 27180989)
42. Corradini R, Feriotto G, Sforza S, Marchelli R, Gambari R (2004) Enhanced recognition of cystic fibrosis W1282X DNA point mutation by chiral peptide nucleic acid probes by a surface plasmon resonance biosensor. J Mol Recognit 17:76-84 (Pubitemid 38231467)
43. Louis DN, Ohgaki H, Wiestler OD, Cavenee WK, Burger PC et al (2007) The 2007 WHO classification of tumours of the central nervous system. Acta Neuropathol 114:97-109 (Pubitemid 47103521)
44. Hermansen SK, Kristensen BW (2013) MicroRNA biomarkers in glioblastoma. J Neurooncol 114:13-23
45. Rothbard JB, Kreider E, Van Deusen CL, Wright L, Wylie BL (2002) Arginine-rich molecular transporters for drug delivery: role of backbone spacing in cellular uptake. J Med Chem 45:3612-3618 (Pubitemid 34856101)
46. Qian X, Ren Y, Shi Z, Long L, Pu P et al (2012) Sequence-dependent synergistic inhibition of human glioma cell lines by combined temozolomide and miR-21 inhibitor gene therapy. Mol Pharm 9:2636-2645
47. Chen L, Zhang J, Han L, Zhang A, Zhang C et al (2012) Down regulation of miR-221/222 sensitizes glioma cells to temozolomide by regulating apoptosis independently of p53 status. Oncol Rep 27:854-860
48. Suzuki T, Wu D, Schlachetzki F, Li JY, Boado RJ (2004) Imaging endogenous gene expression in brain cancer in vivo with 111In-peptide nucleic acid antisense radiopharmaceuticals and brain drug-targeting technology. J Nucl Med 45:1766-1775 (Pubitemid 47618489)
49. Boado RJ, Tsukamoto H, Pardridge WM (1998) Drug delivery of antisense molecules to the brain for treatment of Alzheimer's disease and cerebral AIDS. J Pharm Sci 87:1308-1315
50. Sethi D, Chen CP, Jing RY, Thakur ML, Wickstrom E (2012) Fluorescent peptide-PNA chimeras for imaging monoamine oxidase A mRNA in neuronal cells. Bioconjug Chem 23:158-163